Page 1 of Clinical Trials for BI 1356, 40 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
2
Completed
Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
3
Completed
Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
4
Completed
Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
5
Completed
Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
6
Completed
Japanese P III vs Voglibose and Placebo
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
7
Recruiting
30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by 54 Week Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes
Last Updated: April 4, 2012
Condition(s): Diabetes Mellitus, Type 2
8
Completed
BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
9
Completed
Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
10
Completed
A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
11
Completed
Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
12
Completed
Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic Patients
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
13
Completed
The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
14
Completed
Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
15
Completed
Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
16
Completed
Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
17
Completed
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study
Last Updated: March 7, 2012
Condition(s): Diabetes Mellitus, Type 2
18
Recruiting
Finding a Safe and Effective Dose of Linagliptin in Peadiatric Patients With Type 2 Diabetes
Last Updated: May 2, 2012
Condition(s): Diabetes Mellitus, Type 2
19
Recruiting
Efficacy and Safety of BI 10773/BI 1356 Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients
Last Updated: May 2, 2012
Condition(s): Diabetes Mellitus, Type 2
20
Completed
Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=BI+1356

Page 1 of Clinical Trials for BI 1356, 40 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About